Latest KFF Health News Stories
Effective but Underprescribed: HIV Prevention Meds Aren’t Reaching Enough People
PrEP has been available for more than a decade, but billing mistakes, lack of awareness, and lingering stigma keep many people from getting the lifesaving HIV prevention medication.
It’s 2026 and You’re Uninsured. Now What?
Many Americans are expected to lose ACA or Medicaid coverage in coming months and years as a result of the One Big Beautiful Bill Act and the expiration of enhanced pandemic-era subsidies that helped people afford Obamacare plans. Doctors and researchers say there are still ways to find affordable care.
Es 2026 y no tienes seguro médico. ¿Y ahora qué?
Los cambios en las políticas de salud en Washington están teniendo repercusiones en todo el país y haciendo que millones de personas pierdan su cobertura de Medicaid o de ACA. Pero hay opciones.
This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul.
The federal government’s Vaccine Injury Compensation Program was supposed to help patients with their medical bills while protecting vaccine supply. But allies of Health and Human Services Secretary Robert F. Kennedy Jr. are routinely transferring cases from that program to launch lawsuits against drugmakers.
Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026
With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents — and they’re frustrated that the Trump administration isn’t doing more to limit its use.
What the Health? From KFF Health News: Health Spending Is Moving in Congress
Lawmakers appear on the brink of passing a spending bill for the Department of Health and Human Services and a bipartisan health policy bill delayed for over a year. But the outlook is bleaker for the health care outline released by President Trump last week. Sandhya Raman of CQ Roll Call, Sheryl Gay Stolberg of The New York Times, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews oncologist and bioethicist Ezekiel Emanuel to discuss his new book, “Eat Your Ice Cream.”
Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.
Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study
KFF Health News’ editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a collection of her appearances.
What the Health? From KFF Health News: Culture Wars Take Center Stage
With lawmakers still mired over renewing enhanced tax credits for Affordable Care Act plans, much of Washington has turned to culture war issues. Meanwhile, “confusion” remains the watchword at HHS as personnel and funding decisions continue to be made and unmade with little notice. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews KFF Health News’ Elisabeth Rosenthal, who wrote the latest “Bill of the Month” report.
California Ends Medicaid Coverage of Weight Loss Drugs Despite TrumpRx Plan
Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead. California and other states say the drugs are too costly, even as the Trump administration announces plans to lower prices.
Seis tips para obtener fármacos que previenen el VIH superando obstáculos del sistema de salud
Los CDC calculan que 2,2 millones de personas en Estados Unidos podrían beneficiarse del uso de medicamentos preventivos contra el VIH, pero solo poco más de una cuarta parte los recibe.
To Knock Down Health-System Hurdles Between You and HIV Prevention, Try These 6 Things
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
FDA cuestiona uso de antidepresivos en el embarazo, pero médicos dicen que son esenciales
A expertos médicos les preocupa que una mesa redonda convocada en julio por la Administración de Alimentos y Medicamentos pueda provocar más casos de depresión no tratada.
FDA Panelists Questioned Antidepressants in Pregnancy. But Doctors Call Them a Lifeline.
Participants in an FDA panel discussion warned the public about risks from using antidepressants in pregnancy. But mental health issues, including suicide and overdoses, are the leading cause of maternal death in the United States. Antidepressants are a safe, well-studied way to help prevent those deaths, medical experts say.
In RFK Jr.’s Upside-Down World of Vaccines, Panel Votes To End Hepatitis B Shot at Birth
A session of a vaccine panel dominated by skeptics was chaotically at odds with past practices of the CDC, which HHS Secretary Robert F. Kennedy Jr. has described as a “cesspool of corruption.” His crew voted to end a 34-year recommendation to vaccinate newborns against hepatitis B.
What the Health? From KFF Health News: The Government Is Open
The record-long federal shutdown is over after a small group of Democrats agreed to a deal with most Republicans that funds the government through January — but, notably, does not extend more generous Affordable Care Act tax credits. Plus, new details are emerging about how the Trump administration is using the Medicaid program to advance its policy goals. Anna Edney of Bloomberg News, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, KFF Health News’ Julie Rovner interviews KFF Health News’ Julie Appleby, who wrote the latest “Bill of the Month” feature.
What the Health? From KFF Health News: Happy Open Enrollment Eve!
A standoff in Congress is keeping much of the government shut down as open enrollment begins in most states for Affordable Care Act plans. Democrats are demanding Republicans agree to extend ACA tax credits, but there has been little negotiating — even as customers are learning what they’ll pay for coverage next year. Meanwhile, the Trump administration is telling states they can’t pass their own laws to keep medical debt off consumers’ credit reports. Paige Winfield Cunningham of The Washington Post, Maya Goldman of Axios, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more.
Luego de criticar a demócratas por su política transgénero, Newsom veta una medida de salud clave
La ley habría obligado a las aseguradoras a cubrir y a las farmacéuticas a dispensar 12 meses de terapia hormonal de una sola vez a pacientes transgénero y a otras personas.
After Chiding Democrats on Transgender Politics, Newsom Vetoes a Key Health Measure
California Gov. Gavin Newsom vetoed a bill that would have expanded access to hormone therapy, a top priority for the trans community. Advocates say it would have ensured continuity in gender-affirming care amid Trump administration attacks. Analysts say it’s another sign of the Democrat’s move to the center.
What the Health? From KFF Health News: Schrödinger’s Government Shutdown
Democrats and Republicans remain stalled over funding the federal government as Republicans launch a new attack on the Affordable Care Act. Meanwhile, the Trump administration is taking advantage of the shutdown to lay off workers from programs supported mostly by Democrats. Anna Edney of Bloomberg News, Lauren Weber of The Washington Post, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews health insurance analyst Louise Norris about Medicare open enrollment.
